Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia
about
Resveratrol and clinical trials: the crossroad from in vitro studies to human evidenceChallenges in Analyzing the Biological Effects of ResveratrolNovel nutraceutic therapies for the treatment of metabolic syndromeResveratrol and Cardiovascular DiseasesModulation of Hypercholesterolemia-Induced Oxidative/Nitrative Stress in the HeartCardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapiesEarly Cellular Changes in the Ascending Aorta and Myocardium in a Swine Model of Metabolic SyndromeRetinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseasesResveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective.Investigating the effects of resveratrol on chronically ischemic myocardium in a swine model of metabolic syndrome: a proteomics analysis.Synergistic effects of polyphenols and methylxanthines with Leucine on AMPK/Sirtuin-mediated metabolism in muscle cells and adipocytesThe effects of resveratrol in rats with simultaneous type 2 diabetes and renal hypertension: a study of antihypertensive mechanisms.Vodka and wine consumption in a swine model of metabolic syndrome alters insulin signaling pathways in the liver and skeletal muscleResveratrol preserves myocardial function and perfusion in remote nonischemic myocardium in a swine model of metabolic syndrome.Are sirtuins viable targets for improving healthspan and lifespan?Unique vascular protective properties of natural products: supplements or future main-line drugs with significant anti-atherosclerotic potential?Effects of the PPAR-β/δ agonist GW0742 during resuscitated porcine septic shock.Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome.Does resveratrol improve insulin signaling in chronically ischemic myocardium?Resveratrol regulates autophagy signaling in chronically ischemic myocardium.Resveratrol in the prevention and treatment of coronary artery disease.Autophagy, myocardial protection, and the metabolic syndrome.The pig as a valuable model for testing the effect of resveratrol to prevent cardiovascular disease.Current evidence for AMPK activation involvement on resveratrol-induced neuroprotection in cerebral ischemia.Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice.Metabolic syndrome is not a predictor for cardiovascular events in Japanese patients with diabetes mellitus asymptomatic for coronary artery disease: a retrospective analysis of the J-ACCESS-2 study.
P2860
Q24618313-F6F43E43-8181-4C27-B04B-F2AC13F5C875Q26746257-B1B9035C-4CE8-4A4F-9D2F-AB5A936312C4Q26748558-C1FF767D-1252-4DB2-B827-04F915273816Q26752801-F434D7E2-B767-4718-B054-437C47F31620Q26770809-112A16E5-5A03-41A9-A311-6E02CFAF5A26Q27002459-AA5A9C19-C7CC-4E3D-A53B-99F50A2B26BCQ27332290-9DC69273-9C4D-4731-9C57-7E0426A8236EQ28082224-DC64CCC5-C25C-4894-8DBF-F9BCB876B4A7Q34357562-2AC50F53-114D-4172-98C5-9BD6890661AFQ34802630-006C8CFE-2FF3-4664-A9B7-E691C4FF6D30Q35097761-37583E8E-DEA0-4D2F-B545-8EF468095A46Q35178316-C438DCEE-3F28-40FA-B97D-43673412AF4FQ36213947-832DC162-94FA-4675-AEAC-DBA7B4E73E62Q36339075-38EADC55-2C52-4B68-996F-37AF8634A271Q36385747-2EACD12E-5B22-4D93-BE6D-99D2602C2725Q36429790-D37B529D-F118-4D6A-844A-9AB00E099FB6Q36698636-B098C77A-D3D8-4239-8F08-E3737064D537Q36966329-F9073ECE-CC61-4C21-BE69-1A1FD914E664Q37086519-B66E3B59-F957-4ACF-812F-3BB03E0BFF8DQ37625785-DDA1792B-A9C2-4962-8E18-AC39EE9B59B1Q37922623-8D0F298B-0660-46F6-8E68-2B10A547204BQ37999635-2BAA478C-D1A4-4252-BA81-EBED14ECAEB7Q38121606-8A0754F9-4B18-411E-92FF-6F900F607BBDQ38757843-50908AE3-ACAD-4B0F-9C09-297C514E9931Q42354127-96C2D0EF-FC0D-4C3A-9FF3-EDC8A8AFBCA3Q53130672-E61C5CE8-38E3-4011-AA1F-F3F2FF450062
P2860
Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Resveratrol modifies risk fact ...... ndrome and myocardial ischemia
@ast
Resveratrol modifies risk fact ...... ndrome and myocardial ischemia
@en
type
label
Resveratrol modifies risk fact ...... ndrome and myocardial ischemia
@ast
Resveratrol modifies risk fact ...... ndrome and myocardial ischemia
@en
prefLabel
Resveratrol modifies risk fact ...... ndrome and myocardial ischemia
@ast
Resveratrol modifies risk fact ...... ndrome and myocardial ischemia
@en
P2093
P2860
P1476
Resveratrol modifies risk fact ...... ndrome and myocardial ischemia
@en
P2093
Frank W Sellke
Louis M Chu
Michael P Robich
Reza Nezafat
Richard T Clements
Robert M Osipov
P2860
P356
10.1016/J.EJPHAR.2011.04.059
P407
P577
2011-05-07T00:00:00Z